High density lipoprotein apolipoprotein AI kinetics in NIDDM: A stable isotope study

Diabetologia

Volumn 40, Issue 5, 1997, Pages 578-583

  Frenais R ^a   Ouguerram, K ^a   Maugeais, C ^a   Mahot, P ^b   Maugere P ^a   Krempf, M ^a,b   Magot, T ^a  

^a CHU de Nantes   (France)

^b Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

Author keywords

apolipoprotein AI; fractional catabolic rate; HDL cholesterol; kinetic analysis; non insulin dependent diabetes mellitus; stable isotope

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LEUCINE; STABLE ISOTOPE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KINETICS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030952963     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050718     Document Type: Article

References (32)

1. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL (1982) Abnormal composition of high density lipoproteins in noninsulin-dependent diabetics. Diabetes 31: 126-131
2. Briones ER, Mao SJT, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA (1984) Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics. Metabolism 33: 42-49
3. Forte TM, McCall MR (1994) The role of apolipoprotein AI-containing lipoproteins in atherosclerosis. Curr Opin Lipidol 5: 354-364
4. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62: 707-714
5. Avogaro PG, Bittolo Bon G, Cazzolato G, Quinci GB (1979) Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet i: 901-903
6. Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer HBJ (1993) Evaluation of apo AI kinetics in human using simultaneous endogenous stable isotope and exogenous radiotracers methods. J Lipid Res 34: 2207-2215
7. Golay A, Zech L, Shi MZ, Chiou YAM, Reaven GM, Chen YDI (1987) High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of DHL turnover using tritiated HDL. J Clin Endocrinol Metab 65: 512-518
8. Golay A, Zech L, Shi MZ, Chiou YAM, Chen YDI (1985) High density lipoprotein (HDL) turnover in noninsulin-dependent diabetes mellitus (NIDDM). Diabetes 34: 81 A (Abstract)
9. Schaefer JR, Rader DJ, Brewer HBJ (1992) Investigation of lipoprotein kinetics using endogenous labeling with stable isotopes. Curr Opin Lipidol 3: 227-232
10. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM (1981) A density gradient ultracentrifugal procerdure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 22: 339-358
11. Mindham MA, Mayes PA (1992) A simple and rapid method for preparation of apolipoproteins for electrophoresis. J Lipid Res 33: 1084-1088
12. Foster DM, Barrett PHR, Toffolo G, Beltz WF, Cobelli C (1993) Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 34: 2193-2205
13. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD (1965) Blood volume measurement: a critical study. Prediction of normal values, controlled measurement of sequential changes, choice of a bedside method. Advanc Surg 1: 69-109
14. Schaefer EJ, Zech LA, Jenkins LL (1982) Human apolipoprotein AI and AII metabolism. J Lipid Res 23: 850-862
15. Schaefer EJ, Foster DM, Jenkins LL, Lindgren FT, Berman M, Levy RI, Brewer HBJ (1979) The composition and metabolism of high density lipoprotein subfractions. Lipids 14: 511-522
16. Walsh BW, Li H, Sacks FM (1994) Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 35: 2083-2093
17. Brinton EA, Eisenberg S, Breslow JL (1991) Increased apo AI and apo AII fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest 87: 536-544
18. Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ (1992) Metabolism of HDL apolipoprotein AI and AII in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 347-356
19. Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HBJ (1991) In vivo metabolism of apolipoprotein AI on high density lipoprotein particles Lp AI and Lp AI : AII. J Lipid Res 32: 1849-1859
20. Brinton EA, Eisenberg S, Breslow JL (1989) Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein AI and AII fractional catabolic rate in women. J Clin Invest 84: 262-269
21. Ikewaki K, Zech LA, Brewer HBJ, Rader DJ (1996) Apo AII kinetics in human using endogenous labeling with stable isotopes: slower turnover of apo AII compared with the exogenous radiotracer method. J Lipid Res 37: 399-407
22. Zech LA, Schaefer EJ, Bronzen TJ, Aamodt RL, Brewer HBJ (1983) Metabolism of human apolipoprotein AI and AII: compartmental models. J Lipid Res 24: 60-71
23. Rader DJ, Ikewaki K (1996) Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animals models. Curr Opin Lipidol 7: 117-123
24. Ikewaki K, Zech LA, Kindt M, Brewer HBJ, Rader DJ (1995) Apolipoprotein AII production rate is a major factor regulating the distribution of apolipoprotein AI among HDL subclasses Lp AI and Lp AI : AII in normolipidemic humans. Arterioscler Thromb Vasc Biol 15: 306-312
25. Kaysen GA, Hove E, Jones HJ (1995) Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats. Am J Physiol 268: F532-F540
26. Ahnadi CE, Masmoudi T, Berthezene F, Ponsin G (1993) Decreased ability of high density lipoproteins to transfer cholesterol esters in noninsulin-dependent diabetes mellitus. Eur J Clin Invest 23: 191-196
27. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL (1993) Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. J Clin Invest 92: 1143-1152
28. Syvänne M, Ahola M, Lahdenperä S, Kahri J, Kuusi T, Virtanen KS, Taskinen MR (1995) High density lipoprotein subfractions in noninsulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36: 573-582
29. Brinton EA, Eisenberg S, Breslow JL (1994) Human HDL cholesterol levels are determined by apo AI fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb 14: 707-720
30. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN (1993) Increased plasma and renal clearance of an exchangeable pool of apolipoprotein AI in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest 91: 1743-1752
31. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC (1993) Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis 104: 69-77
32. Kahri J, Syvänne M, Taskinen MR (1994) Plasma cholesterol ester transfer protein activity in noninsulin-dependent diabetic patients with and without coronary artery disease. Metabolism 43: 1498-1502